NCT04512274

Skin Protectant Properties of Omeza Collagen Matrix on Damaged Skin

A Single Center Study in 22 Healthy Male and Female Subjects to Investigate the Skin Protectant and Anti-Inflammatory Properties of Omeza Collagen Matrix on Damaged Skin

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Omeza, LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Single-blind within subject comparison study conducted to investigate the skin protectant properties of Omeza Collagen Matrix on damaged skin

Detailed description

This study was conducted in 22 healthy subjects to determine the skin protectant and anti-inflammatory properties of the test product. For the skin protectant assay the test article was applied to the forearm and covered with gauze for 10 minutes before assessment of irritation and TEWL readings. An inflammatory skin response was induced by a SLS solution 24 hours prior to application of the test article. The test article was applied for 10 minutes at the site of inflammation. The test site was then graded for irritation and TEWL readings.

Conditions

• Transepidermal Water Loss
• Erythema

Interventions

Type	Name	Description
DEVICE	Test Article	Omeza Collagen Matrix

Timeline

• Start date: 2020-06-01
• Primary completion: 2020-06-05
• Completion: 2020-06-05
• First posted: 2020-08-13
• Last updated: 2022-09-30

Locations

1 site across 1 country: United Kingdom

Regulatory

• FDA-regulated device study